Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer: a Multicenter Randomised Controlled Trial

NCT03465982 is registered in ClinicalTrials.gov with Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria as lead sponsor.

NCT NCT03465982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03465982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer: a Multicenter Randomised Controlled Trial
Lead sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Phase
Not applicable
Overall status
Recruiting
Start date
June 5, 2018
Completion date
June 5, 2029
Enrollment
340 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer